Management of Hypertension Based on Latest Guidelines

Introduction to Hypertension Management

• The European Society of Cardiology recommends initiating upfront combination therapy with two first-line antihypertensive agents for adults with confirmed hypertension, targeting blood pressure <130/80 mm Hg, while implementing comprehensive lifestyle modifications 1, 2

Blood Pressure Classification and Treatment Initiation

• For adults with Stage 1 Hypertension (130-139/80-89 mm Hg) and ASCVD risk ≥10%, the American College of Physicians suggests initiating both lifestyle modifications and pharmacotherapy immediately 3, 2
• The European Heart Journal recommends starting combination pharmacotherapy plus lifestyle modifications for Stage 2 Hypertension (≥140/90 mm Hg), reassessing in 1 month 1, 2

Pharmacological Treatment Algorithm

• The European Society of Cardiology guidelines represent the most current evidence, recommending upfront low-dose combination therapy for most patients with confirmed hypertension, preferably as single-pill combinations to improve adherence 1
• The American Heart Association suggests using ACE inhibitors or ARBs, long-acting dihydropyridine calcium channel blockers, and thiazide-like diuretics as first-line drug classes 5, 1

Blood Pressure Targets

• The American College of Cardiology recommends a blood pressure target of <130/80 mm Hg for adults <65 years, and systolic <130 mm Hg if tolerated for adults ≥65 years (ambulatory, community-dwelling) 3, 2
• The European Society of Cardiology suggests a systolic BP target of 120-129 mm Hg for most adults if well tolerated 6

Lifestyle Modifications

• The American Heart Association recommends the DASH diet pattern, sodium restriction (<2,300 mg/day), potassium supplementation (3,500-5,000 mg/day), and sugar elimination for blood pressure reduction 6
• The European Society of Cardiology suggests achieving and maintaining a healthy BMI (18.5-24.9 kg/m²) and engaging in regular exercise (150 minutes/week moderate-intensity aerobic activity) 6

Follow-Up Schedule and Monitoring

• The American College of Physicians recommends reassessing blood pressure annually for normal BP, 3-6 months for elevated BP or Stage 1 HTN (low risk), and 1 month after treatment initiation for Stage 1 HTN (high risk) or Stage 2 HTN 2
• The European Society of Cardiology suggests monitoring renal function and potassium at least annually when using ACE inhibitors, ARBs, or diuretics 6

Strategies to Improve Treatment Adherence

• The American Heart Association recommends using single-pill combinations, team-based care, and technology integration to enhance adherence 4, 2
• The European Society of Cardiology suggests using motivational interviewing and goal-setting strategies to improve patient engagement 2

Special Considerations for Resistant Hypertension

• The American College of Physicians defines resistant hypertension as BP ≥130/80 mm Hg despite adherence to three or more antihypertensive agents from different classes at optimal doses 4
• The European Society of Cardiology recommends maximizing diuretic therapy, using loop diuretics in patients with CKD, and adding mineralocorticoid receptor antagonist for treatment optimization 4, 1